Drugplain

Leader Triple antibiotic 400 [USP'U]/g

Bacitracin,Neomycin,Polymxin · OINTMENT · Cardinal Health 110 dba LEADER

No Recall History
Plain English

Leader Triple antibiotic is a ointment containing bacitracin,neomycin,polymxin at 400 [USP'U]/g, taken topical. Manufactured by Cardinal Health 110 dba LEADER.

Key Facts

Brand Name
Leader Triple antibiotic
Generic Name
Bacitracin,Neomycin,Polymxin
NDC Code (Product)
70000-0687
Manufacturer
Cardinal Health 110 dba LEADER
Strength
400 [USP'U]/g
Dosage Form
OINTMENT
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
08/15/2024

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses First Aid to help prevent infection in minor Cuts Scrapes Burns

Dosage & Administration

Directions Clean the affected area and dry thoroughly Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily May be covered with a sterile bandage

Warnings

Warnings For external use only. Do not use: In eyes Over large areas of the body If you are allergic to any of the ingredients

Frequently Asked Questions

What is Leader Triple antibiotic used for?

Leader Triple antibiotic contains Bacitracin,Neomycin,Polymxin. It is a ointment taken topical. Consult your doctor for specific uses.

Is Leader Triple antibiotic a controlled substance?

Leader Triple antibiotic is not classified as a controlled substance by the DEA.

What is the generic name for Leader Triple antibiotic?

The generic name for Leader Triple antibiotic is Bacitracin,Neomycin,Polymxin. There are 4 other brand versions of Bacitracin,Neomycin,Polymxin.

What is the NDC code for Leader Triple antibiotic 400 [USP'U]/g?

The NDC (National Drug Code) for Leader Triple antibiotic 400 [USP'U]/g is 70000-0687, listed by Cardinal Health 110 dba LEADER.

Product NDC

70000-0687

Package NDC

70000-0687-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)